treosulfan zentiva 5 g proszek do sporządzania roztworu do infuzji
zentiva, k.s. - treosulfan - proszek do sporządzania roztworu do infuzji - 5 g
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - środki agenci - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.